Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Alaunos Therapeutics, Inc. TCRT

Full chart Compare
Set alert

Price alert · TCRT

All alert types
1.84 USD +0.04 (+2.22%)

At closeNov 6, 2026, 6:48 AM EST

1.81 -0.03 -1.63%

Pre-market · Nov 6, 6:48 AM ET

1.73 Day range 1.84
0.72 52-week range 4.50
YTD
-43.03%
1 year
-25.20%

Financial health

Altman Z-Score

-860.17 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C-1 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -1.5×
FY 2016: -4.2×FY 2017: -10.4×FY 2018: -5.1×FY 2019: -4.5×FY 2020: -6.7×FY 2021: -3.0×FY 2022: -3.7×FY 2023: -0.5×FY 2024: -0.7×FY 2025: -1.5×
FY 2016 5y median -1.5× FY 2025
P/S 1259×
FY 2016: 102×FY 2017: 88.7×FY 2018: 1838×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 587×FY 2022: 48.2×FY 2023: 3394×FY 2024: 306×FY 2025: 1259×
FY 2016 5y median 587× FY 2025
P/B 2.9×
FY 2016: -9.0×FY 2017: -5.9×FY 2018: 3.1×FY 2019: 8.3×FY 2020: 4.3×FY 2021: 4.0×FY 2022: 3.7×FY 2023: 2.7×FY 2024: 1.5×FY 2025: 2.9×
FY 2016 5y median 2.9× FY 2025
P/FCF -2.1×
FY 2016: -11.8×FY 2017: -10.2×FY 2018: -5.4×FY 2019: -19.3×FY 2020: -7.9×FY 2021: -3.6×FY 2022: -4.8×FY 2023: -0.6×FY 2024: -0.6×FY 2025: -2.1×
FY 2016 5y median -2.1× FY 2025
EV/EBITDA -1.2×
FY 2016: -3.7×FY 2017: -9.3×FY 2018: -3.9×FY 2019: -6.1×FY 2020: -5.3×FY 2021: -2.5×FY 2022: -3.8×FY 2023: -0.4×FY 2024: -0.4×FY 2025: -1.2×
FY 2016 5y median -1.2× FY 2025
EV/Sales 982×
FY 2016: 89.9×FY 2017: 77.6×FY 2018: 1415×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 472×FY 2022: 41.7×FY 2023: 2182×FY 2024: 197×FY 2025: 982×
FY 2016 5y median 472× FY 2025
FCF Yield -47.1%
FY 2016: -8.4%FY 2017: -9.8%FY 2018: -18.6%FY 2019: -5.2%FY 2020: -12.6%FY 2021: -27.7%FY 2022: -20.9%FY 2023: -178.8%FY 2024: -162.5%FY 2025: -47.1%
FY 2016 5y median -47.1% FY 2025

Profitability

Gross Margin -27160.0%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -11778.1%FY 2022: -670.6%FY 2023: -95960.0%FY 2024: -3520.0%FY 2025: -27160.0%
FY 2016 5y median -11778.1% FY 2025
Operating Margin -84500.0%
FY 2016: -2409.4%FY 2017: -837.3%FY 2018: -36921.9%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -19484.7%FY 2022: -1201.4%FY 2023: -685340.0%FY 2024: -48120.0%FY 2025: -84500.0%
FY 2016 5y median -48120.0% FY 2025
Net Margin -83520.0%
FY 2016: -2409.2%FY 2017: -850.3%FY 2018: -36381.5%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -19786.7%FY 2022: -1291.2%FY 2023: -702800.0%FY 2024: -46790.0%FY 2025: -83520.0%
FY 2016 5y median -46790.0% FY 2025
ROE -194.0%
FY 2016: 213.8%FY 2017: 56.1%FY 2018: -62.1%FY 2019: -124.0%FY 2020: -64.5%FY 2021: -135.6%FY 2022: -97.9%FY 2023: -557.2%FY 2024: -226.8%FY 2025: -194.0%
FY 2016 5y median -194.0% FY 2025
ROIC -196.2%
FY 2016: -182.6%FY 2017: -63.1%FY 2018: -63.0%FY 2019: -59.4%FY 2020: -62.4%FY 2021: -88.0%FY 2022: -59.9%FY 2023: -543.3%FY 2024: -233.3%FY 2025: -196.2%
FY 2016 5y median -196.2% FY 2025
ROA -140.8%
FY 2016: -155.4%FY 2017: -51.4%FY 2018: -55.9%FY 2019: -108.0%FY 2020: -54.6%FY 2021: -83.0%FY 2022: -58.1%FY 2023: -425.3%FY 2024: -169.8%FY 2025: -140.8%
FY 2016 5y median -140.8% FY 2025

Growth (YoY)

Revenue -50.0%
FY 2016: 58.4%FY 2017: -6.9%FY 2018: -97.7%FY 2019: -100.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 634.2%FY 2023: -99.8%FY 2024: 100.0%FY 2025: -50.0%
FY 2016 FY 2025
Operating Income 12.2%
FY 2016: -37.6%FY 2017: 67.6%FY 2018: -0.8%FY 2019: -7.3%FY 2020: -38.9%FY 2021: 3.5%FY 2022: 54.7%FY 2023: 2.4%FY 2024: 86.0%FY 2025: 12.2%
FY 2016 FY 2025
EPS (diluted) 24.7%
FY 2016: -32.4%FY 2017: 68.7%FY 2018: 6.8%FY 2019: -186.6%FY 2020: 64.5%FY 2021: 4.6%FY 2022: 51.7%FY 2023: 15.4%FY 2024: 86.7%FY 2025: 24.7%
FY 2016 FY 2025
Free Cash Flow 40.3%
FY 2016: -13851.7%FY 2017: 5.9%FY 2018: 9.9%FY 2019: 17.6%FY 2020: -62.4%FY 2021: 3.0%FY 2022: 54.5%FY 2023: -3.0%FY 2024: 83.6%FY 2025: 40.3%
FY 2016 FY 2025

Financial Health

Current Ratio 2.4×
FY 2016: 6.6×FY 2017: 4.4×FY 2018: 8.9×FY 2019: 8.4×FY 2020: 7.1×FY 2021: 4.9×FY 2022: 2.2×FY 2023: 4.2×FY 2024: 4.0×FY 2025: 2.4×
FY 2016 5y median 4.0× FY 2025
Quick Ratio 2.4×
FY 2016: 6.6×FY 2017: 4.4×FY 2018: 8.9×FY 2019: 8.4×FY 2020: 7.1×FY 2021: 4.9×FY 2022: 1.6×FY 2023: 4.2×FY 2024: 4.0×FY 2025: 2.4×
FY 2016 5y median 4.0× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.5×FY 2022: 0.5×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: 0.5×FY 2017: 1.3×FY 2018: 1.2×FY 2019: 0.7×FY 2020: 1.4×FY 2021: 0.6×FY 2022: 0.6×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: -64.4×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -65.2×FY 2022: -11.1×FY 2023: -17.8×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median -11.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 1.0%FY 2017: 0.0%FY 2018: 6.3%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: -4.3%FY 2017: 0.0%FY 2018: -32.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31